Global Transdermal Skin Patches Market Is Estimated To Witness High Growth Owing To Increasing Demand for Convenient Drug Delivery Method
![]() |
Transdermal Skin Patches Market |
The
global transdermal skin patches market is estimated to be valued at US$ 7,695.0 Mn In 2021 and is expected
to exhibit a CAGR of 5.0% over the
forecast period 2022-2028, as highlighted in a new report published by Coherent
Market Insights.
Market Overview: Transdermal skin patches are adhesive patches that deliver
drugs through the skin and into the bloodstream. They are a convenient and
non-invasive method of drug delivery, providing advantages such as controlled
release, prolonged drug action, and decreased side effects. These patches are
widely used for the treatment of various conditions such as pain management,
hormonal therapy, cardiovascular diseases, and smoking cessation. The increasing
demand for a convenient drug delivery method and the growing prevalence of
chronic diseases are driving the growth of the transdermal skin patches market.
Market Key Trends: One key trend in the Transdermal
Skin Patches Market is the development of advanced drug delivery
systems. Pharmaceutical companies are investing in research and development to
improve the efficiency and effectiveness of transdermal patches. For example,
Purdue Pharma Manufacturing LP has developed Butrans, a transdermal patch for chronic
pain management that provides continuous release of medication for up to seven
days. These advancements in drug delivery technology are expected to drive
market growth.
PEST Analysis:
- Political: Governments play a crucial role in determining regulations related
to the production, marketing, and sale of transdermal skin patches. The
approval process for these patches may vary across different regions, affecting
market growth.
- Economic: The economic landscape of a region, including factors such as disposable
income and healthcare expenditure, influences the demand for transdermal skin
patches.
- Social: Increasing awareness about the advantages of transdermal drug
delivery systems and the need for convenient treatment options among patients
are contributing to market growth.
- Technological: Advancements in drug delivery technologies, such as
microneedle patches and iontophoretic patches, are enhancing the efficacy and
convenience of transdermal skin patches.
Key Takeaways:
- The global Transdermal
Skin Patches Market is expected to witness high growth, exhibiting a
CAGR of 5.0% over the forecast period, due to increasing demand for a
convenient drug delivery method. The advantages of transdermal patches, such as
controlled release and decreased side effects, are driving their adoption.
- North America is expected to dominate the transdermal skin patches market,
owing to the presence of key market players, high healthcare expenditure, and a
growing geriatric population.
- Key players operating in the global transdermal skin patches market include
Henan Lingrui Pharmaceutical Ltd, Purdue Pharma Manufacturing LP, Luye Pharma
Group, 3M Company, Mylan (Viatris), Teva Pharmaceutical Industries Ltd, Samyang
Biopharmaceuticals Corp. (Samyang Holdings), Novartis, and Teikoku Pharma USA
Inc. (Teikoku Seiyaku Co. Ltd). These companies are focusing on product
development and strategic collaborations to strengthen their market presence.
In conclusion, the global transdermal skin patches market is poised for significant
growth in the coming years. The increasing demand for a convenient drug
delivery method, coupled with advancements in drug delivery technology, is
expected to drive market growth. Strategic collaborations and product
development initiatives by key players will further contribute to the expansion
of the market.
Comments
Post a Comment